Literature DB >> 8282789

Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

J J Zwaginga1, H A Koomans, J J Sixma, T J Rabelink.   

Abstract

Increased in vitro platelet aggregability and hypercoagulability are generally held to be main determinants in the prethrombotic state in nephrosis. In vivo, however, thrombotic events depend on the dynamic interaction of flowing blood with the vessel wall. The present study confirms that aggregability of platelets of nephrotic patients is significantly increased by mere stirring or by exogenous stimuli as adenosine diphosphate and arachidonic acid. Moreover, the nephrotic patients have high von Willebrand factor and decreased red blood cell deformability, which normally increase platelet-vessel wall interaction. However, perfusion studies under well-defined flow conditions, in which anticoagulated nephrotic blood was exposed to deendothelialized human umbilical artery segments and sprayed collagen, showed normal platelet adhesion and only a modest increase in the deposition of platelet aggregates. This suggests that some factor counteracts platelet-vessel wall interaction under flow conditions in the nephrotic syndrome. When tissue factor associated with endothelial extracellular matrix (ECM) was allowed to generate thrombin, perfusions with nephrotic blood over this ECM resulted in a strong increase in fibrin generation. The capacity of patient blood to form increased amounts of fibrin appeared strongly correlated with the level of hyperfibrinogenemia. Platelet adhesion as well as aggregation in these experiments was even decreased below control values. This suggests that fibrin coverage may block the direct contact between blood platelets and matrix. We therefore also studied the isolated effect of high fibrinogen on platelet-vessel wall interaction by increasing fibrinogen concentrations in normal blood. Modulation of fibrinogen concentrations in normal blood could mimic all the observations in nephrotic blood: platelet aggregation in suspension increased with increasing concentrations of fibrinogen, while platelet adhesion and aggregate formation under flow conditions decreased. In perfusions over tissue factor-rich matrix, fibrin deposition increased. Therefore, our observations indicate that nephrotic hyperaggregability in suspension is not associated with increased platelet vessel wall-interaction under flow conditions. The latter is probably counteracted by high levels of fibrinogen. Our observations further suggest that hyperfibrinogenemia may be a major thrombotic risk factor in nephrosis by inducing more fibrin depositions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282789      PMCID: PMC293754          DOI: 10.1172/JCI116947

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi.

Authors:  H R Baumgartner
Journal:  Microvasc Res       Date:  1973-03       Impact factor: 3.514

Review 2.  Coagulation and thromboembolic complications in the nephrotic syndrome.

Authors:  J S Cameron
Journal:  Adv Nephrol Necker Hosp       Date:  1984

3.  Metabolic energy is required in human platelets at any stage during optical aggregation and secretion.

Authors:  A J Verhoeven; M E Mommersteeg; J W Akkerman
Journal:  Biochim Biophys Acta       Date:  1984-08-21

4.  The effect of physiological levels of fibrinogen on platelet aggregation.

Authors:  T W Meade; M V Vickers; S G Thompson; M J Seghatchian
Journal:  Thromb Res       Date:  1985-06-01       Impact factor: 3.944

5.  Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance.

Authors:  M R Clark; N Mohandas; S B Shohet
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

6.  Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.

Authors:  T Ishida; K Tanaka
Journal:  Atherosclerosis       Date:  1982-08       Impact factor: 5.162

7.  Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.

Authors:  U Kuhlmann; J Steurer; K Rhyner; A von Felten; J Briner; W Siegenthaler
Journal:  Clin Nephrol       Date:  1981-05       Impact factor: 0.975

8.  Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.

Authors:  C A Jackson; M Greaves; A D Patterson; C B Brown; F E Preston
Journal:  Br J Haematol       Date:  1982-09       Impact factor: 6.998

9.  Comparison of platelet interaction with subendothelium of human renal and umbilical arteries and the extracellular matrix produced by human venous endothelial cells.

Authors:  K S Sakariassen; J D Banga; P G de Groot; J J Sixma
Journal:  Thromb Haemost       Date:  1984-08-31       Impact factor: 5.249

10.  Red blood cell deformability influences platelets--vessel wall interaction in flowing blood.

Authors:  P A Aarts; R M Heethaar; J J Sixma
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

View more
  12 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats.

Authors:  Aline A da Cunha; Emilene Scherer; Maira J da Cunha; Felipe Schmitz; Fernanda R Machado; Daniela D Lima; Débora Delwing; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-09-23       Impact factor: 3.396

3.  Sudden retinal vein thrombosis in a patient with nephrotic syndrome.

Authors:  Ibrahim Masoodi; Imtiyaz Ahmad Wani; Shabnum Hussain; M S Najar; A R Reshi; Farroq A Qurashi; Shaima Khan
Journal:  BMJ Case Rep       Date:  2011-03-10

4.  Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.

Authors:  Geeta Gyamlani; Miklos Z Molnar; Jun L Lu; Keiichi Sumida; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

Review 5.  Venous Thromboembolism in Kidney Diseases and Genetic Predisposition.

Authors:  Tingting Wu; Liang V Tang; Yu Hu
Journal:  Kidney Dis (Basel)       Date:  2022-04-11

6.  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Authors:  Marco Zaffanello; Milena Brugnara; Vassilios Fanos; Massimo Franchini
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

Review 7.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

Review 8.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

9.  Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency.

Authors:  Andrea Artoni; Serena Maria Passamonti; Alberto Edefonti; Francesca Gianniello; Vittorio Civelli; Ida Martinelli
Journal:  Ital J Pediatr       Date:  2016-02-29       Impact factor: 2.638

Review 10.  Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Suartcha Prueksaritanond; Nasir Hussain
Journal:  Int J Nephrol       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.